首页> 外国专利> T T A medium compostion for regulatory T cells derived from peripheral blood mononuclear cells and cultivation method using the same

T T A medium compostion for regulatory T cells derived from peripheral blood mononuclear cells and cultivation method using the same

机译:T T来源于外周血单核细胞的调节性T细胞的培养基组合物及其使用方法

摘要

The present invention relates to a medium composition for culturing regulated T cells derived from peripheral blood mononuclear cells, and a method for culturing regulated T cells by using the same. More specifically, it has been confirmed that the differentiation of regulated T cells is promoted and the mass-proliferation is possible when an anti-CD3 monoclonal antibody, an anti-CD28 monoclonal antibody, TGF-β, and afzelin are included in the medium composition. In addition, it has been confirmed that regulated T cells proliferated by the method of the present invention can significantly inhibit the activity and proliferation of target immune cells. To this end, the present invention provides a medium composition based on an afzelin and a method for culturing regulated T cells by using the same. In addition, regulated T cells derived from peripheral blood mononuclear cells, which are cultured by the method according to the present invention, can be used for a pharmaceutical composition which is very effective to treat autoimmune diseases. Moreover, the medium composition of the present invention can autonomously treat autoimmune diseases.
机译:本发明涉及用于培养源自外周血单核细胞的调节的T细胞的培养基组合物,以及使用该培养基组合物培养调节的T细胞的方法。更具体地,已经证实,当抗CD3单克隆抗体,抗CD28单克隆抗体,TGF-β和afzelin包含在培养基组合物中时,受调节的T细胞的分化被促进并且大量增殖是可能的。 。另外,已经证实通过本发明的方法增殖的调节的T细胞可以显着抑制靶免疫细胞的活性和增殖。为此,本发明提供了一种基于afzelin的培养基组合物,以及使用该培养基组合物培养受调节的T细胞的方法。另外,通过根据本发明的方法培养的源自外周血单核细胞的调节的T细胞可以用于非常有效地治疗自身免疫疾病的药物组合物。此外,本发明的培养基组合物可以自主治疗自身免疫疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号